Market Closed -
Hong Kong S.E.
04:08:22 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
1.31
HKD
|
-2.24%
|
|
+3.15%
|
-10.27%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,268
|
2,936
|
2,654
|
2,913
|
4,551
|
1,256
|
1,256
|
-
|
Enterprise Value (EV)
1 |
3,095
|
-52.72
|
-58.27
|
420.5
|
2,084
|
-882.5
|
-743.9
|
-440.2
|
P/E ratio
|
-
|
-29.2
x
|
-12
x
|
-14.8
x
|
-14.5
x
|
-9.85
x
|
-6.12
x
|
-5.46
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
37.7
x
|
16.9
x
|
75.8
x
|
37.9
x
|
84.1
x
|
24.4
x
|
-
|
-
|
EV / Revenue
|
18.6
x
|
-0.3
x
|
-1.66
x
|
5.47
x
|
38.5
x
|
-15.6
x
|
-
|
-
|
EV / EBITDA
|
-23.3
x
|
0.28
x
|
0.23
x
|
-1.93
x
|
-5.58
x
|
3.04
x
|
2.54
x
|
1.44
x
|
EV / FCF
|
-27,535,763
x
|
565,548
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.42
x
|
0.84
x
|
0.84
x
|
1.08
x
|
1.79
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,120,685
|
1,106,336
|
1,098,782
|
1,086,734
|
1,087,134
|
1,012,758
|
1,012,758
|
-
|
Reference price
2 |
5.593
|
2.654
|
2.416
|
2.681
|
4.186
|
1.240
|
1.240
|
1.240
|
Announcement Date
|
19-03-24
|
20-03-24
|
21-03-30
|
22-03-21
|
23-03-19
|
24-03-25
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
166.3
|
173.4
|
35
|
76.88
|
54.09
|
56.6
|
-
|
-
|
EBITDA
1 |
-132.7
|
-188.7
|
-258
|
-217.4
|
-373.6
|
-290.5
|
-292.9
|
-305.6
|
EBIT
1 |
-144.7
|
-210.9
|
-285.2
|
-246.9
|
-403.8
|
-308.9
|
-309.4
|
-320.7
|
Operating Margin
|
-86.99%
|
-121.57%
|
-814.86%
|
-321.18%
|
-746.55%
|
-545.88%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-19.87
|
-95.97
|
-209.2
|
-199
|
-314.8
|
-144.7
|
-186.6
|
-193.6
|
Net income
1 |
-7.258
|
-95.97
|
-209.2
|
-199
|
-314.8
|
-144.7
|
-219
|
-242.5
|
Net margin
|
-4.36%
|
-55.33%
|
-597.81%
|
-258.88%
|
-582.07%
|
-255.7%
|
-
|
-
|
EPS
2 |
-
|
-0.0910
|
-0.2012
|
-0.1813
|
-0.2896
|
-0.1347
|
-0.2027
|
-0.2273
|
Free Cash Flow
|
-112.4
|
-93.23
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-67.58%
|
-53.75%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-24
|
20-03-24
|
21-03-30
|
22-03-21
|
23-03-19
|
24-03-25
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
75.4
|
98.04
|
31.83
|
3.167
|
36.55
|
40.33
|
38.22
|
15.87
|
46.51
|
10.09
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-80.33
|
-228.6
|
-177.3
|
-194.3
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-172.73%
|
-2,265.77%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-0.0463
|
-0.0494
|
-0.1518
|
-0.1009
|
-0.0804
|
-0.0810
|
-0.2086
|
-0.0152
|
-0.1195
|
-0.1200
|
-0.1400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-08-29
|
20-03-24
|
20-08-28
|
21-03-30
|
21-08-26
|
22-03-21
|
22-08-22
|
23-03-19
|
23-08-22
|
24-03-25
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
3,173
|
2,989
|
2,712
|
2,493
|
2,467
|
2,266
|
2,000
|
1,696
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-112
|
-93.2
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-0.36%
|
-2.84%
|
-2.6%
|
-6.97%
|
-12%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-0.32%
|
-1.38%
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
2,259
|
6,954
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
3.940
|
3.150
|
2.870
|
2.490
|
2.340
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
15.8
|
18.9
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
9.51%
|
10.89%
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-24
|
20-03-24
|
21-03-30
|
22-03-21
|
23-03-19
|
24-03-25
|
-
|
-
|
Last Close Price
1.24
CNY Average target price
2.752
CNY Spread / Average Target +121.86% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.27% | 173M | | -4.06% | 86.13B | | +1.32% | 39.82B | | +56.72% | 25.23B | | -16.09% | 15.36B | | -9.14% | 11.95B | | -17.69% | 11.6B | | -43.00% | 11.51B | | +6.14% | 8.71B | | -7.02% | 8.12B |
Biopharmaceuticals
|